Anti-PD-1 immunotherapy is effective for patients with specific checkpoint mutations but useless otherwise.

“so someone that has a a pd-1 mutation um the response rate to those people for a an anti-pd-1 drug like katruda is very high and very durable i mean far more than anything you see with chemotherapy absolutely conversely if they don't have the pd-1 mutation the drug is useless um”